Study Overview
The present study explores the intricate relationship between subjective experiences and objective measurements of sleep in individuals diagnosed with functional neurological disorder (FND). FND is characterized by neurological symptoms that do not have a clear organic cause, often manifesting as movement disorders, sensory disturbances, or seizures. Sleep disturbances are commonly reported among patients with FND, impacting their quality of life and overall functioning.
Researchers aimed to address a critical gap in the existing literature by comparing self-reported sleep patterns with data collected through actigraphy, a method that objectively measures sleep and activity levels over time. The study sample comprised a diverse group of participants with varying degrees of functional neurological issues, which allowed for a comprehensive analysis of sleep behaviors across different manifestations of the disorder.
To collect the necessary data, participants were asked to complete standardized self-report questionnaires assessing their sleep quality, including the Pittsburgh Sleep Quality Index (PSQI). Concurrently, they wore actigraphy devices that tracked their sleep-wake patterns over an extended period. This dual approach enabled the researchers to examine discrepancies between subjective perceptions of sleep and actual sleep patterns as recorded by the actigraphy.
The researchers expected to identify significant correlations, as well as potential discrepancies, between these two measurements. By doing so, they aimed to gain insights that could improve understanding of sleep-related challenges in the FND population and inform future therapeutic strategies. Ultimately, the outcomes of this study hold the potential to enhance patient care by addressing the specific sleep needs and concerns of individuals affected by functional neurological disorders.
Methodology
The methodology of this study involved a comprehensive and systematic approach to evaluating sleep patterns in participants diagnosed with functional neurological disorder (FND). The research design included a cross-sectional analysis, combining both quantitative and qualitative data collection methods to achieve a holistic understanding of sleep quality and quantity in this specific patient population.
Participants
A total of 100 individuals diagnosed with FND were recruited for the study. The participants ranged in age from 18 to 65 years, ensuring a wide demographic representation. Participants were selected from neurology clinics and support groups dedicated to FND, ensuring that they met the diagnostic criteria for the disorder. Exclusion criteria included individuals with comorbid sleep disorders, severe psychiatric conditions, or those taking medications that significantly impact sleep patterns.
Data Collection Instruments
To facilitate the investigation, two primary instruments were employed:
- Pittsburgh Sleep Quality Index (PSQI): This self-report questionnaire assesses various dimensions of sleep quality over the past month. It consists of 19 items grouped into seven components, each contributing to a global score that ranges from 0 to 21, with higher scores indicating poorer sleep quality.
- Actigraphy: Each participant wore a wrist-mounted actigraphy device for a successive period of one week. The device utilized accelerometers to objectively record sleep-wake patterns, capturing both the total sleep time (TST) and sleep efficiency (SE). This data provided insights into the natural sleep behaviors of participants in their home environments, free from the biases of self-reporting.
Data Analysis
The data analysis plan involved multiple steps. First, the researchers assessed the validity of self-reported sleep quality against the actigraphy data. Statistical methods, including Pearson correlations and paired t-tests, were employed to identify any significant discrepancies and correlations between the PSQI scores and the measurements gathered through actigraphy.
To facilitate clarity in presenting results, the key sleep parameters were summarized in the following table:
| Parameter | PSQI Score (Mean ± SD) | Actigraphy Data (Median ± IQR) |
|---|---|---|
| Total Sleep Time (TST) (hours) | 7.4 ± 1.3 | 6.5 ± 1.2 |
| Sleep Efficiency (SE) (%) | 72.5 ± 15.0 | 65.0 ± 10.0 |
| Sleep Quality Score | 8.6 ± 3.5 | N/A |
For comprehensive insight, subgroup analyses were also conducted based on various characteristics of the participants, such as age, gender, and specific FND manifestations.
Ethical Considerations
Ethical approval was obtained from the institutional review board prior to commencement of the study. Informed consent was collected from all participants, ensuring that they understood the aims of the study and their right to withdraw at any point without consequence.
This rigorous methodological framework allowed for the reliable comparison of subjective and objective sleep measures, providing a foundation for the subsequent analysis of the findings.
Key Findings
The analysis of the collected data revealed several noteworthy findings regarding sleep patterns in individuals with functional neurological disorder (FND). Comparison between self-reported sleep metrics and actigraphy data highlighted significant discrepancies that warrant attention.
Firstly, the mean score of the Pittsburgh Sleep Quality Index (PSQI) was found to be 8.6 ± 3.5. This indicates that, on average, participants reported sleep quality that is typically categorized as “poor,” as scores higher than 5 signify sleep disturbances. In contrast, actigraphic measurements indicated a total sleep time (TST) of 6.5 ± 1.2 hours and a sleep efficiency (SE) of 65.0 ± 10.0%. This discrepancy suggests that while patients perceived their sleep to be better than it objectively was, the objective data indicated considerable sleep deprivation and inefficiency.
The correlations between PSQI scores and actigraphy measurements revealed statistically significant relationships. A Pearson correlation analysis showed a negative correlation between PSQI scores and both TST (r = -0.45, p < 0.001) and SE (r = -0.50, p < 0.001). This indicates that higher PSQI scores, reflective of poorer subjective sleep quality, were associated with shorter TST and lower SE, affirming the impact of perceived sleep quality on actual sleep patterns. Additionally, subgroup analyses underlined the diversity of sleep experiences among FND patients. For instance, participants with more pronounced motor symptoms reported worse sleep quality than those with predominantly sensory disturbances. Specifically, the mean PSQI score for those with severe movement disorders was 10.2 ± 4.0, compared to 6.1 ± 2.8 for those with milder symptoms. The table below summarizes key sleep metrics across different demographic subgroups:
| Subgroup | PSQI Score (Mean ± SD) | Total Sleep Time (hours) (Median ± IQR) | Sleep Efficiency (%) (Median ± IQR) |
|---|---|---|---|
| Severe Movement Disorders | 10.2 ± 4.0 | 5.7 ± 1.5 | 62.0 ± 12.0 |
| Mild Movement Disorders | 7.0 ± 3.0 | 7.5 ± 1.0 | 70.0 ± 9.0 |
| Sensory Disturbances | 6.1 ± 2.8 | 7.0 ± 1.3 | 68.0 ± 8.0 |
These findings suggest that not only do sleep disturbances significantly affect the daily lives of individuals with FND, but they also highlight the complexity and variability of sleep issues based on the severity of neurological symptoms.
Furthermore, qualitative feedback from participants revealed common themes of frustration regarding sleep, with many expressing a sense of helplessness and confusion about their sleep quality. This emotional component underscores the necessity for clinicians to address both the physical and psychological aspects of sleep in FND patients.
Overall, these results emphasize the importance of utilizing both subjective and objective measures when assessing sleep disturbances in patient populations like those with FND. The divergence between self-reported experiences and objective findings sheds light on the multifaceted nature of sleep and reinforces the need for individualized treatment strategies focused on improving sleep outcomes in this population.
Clinical Implications
The outcomes from this study carry significant implications for the clinical management and therapeutic approaches for individuals suffering from functional neurological disorder (FND). The discrepancies observed between subjective sleep reports and objective actigraphy data underscore the necessity for healthcare providers to adopt a multifaceted perspective when evaluating sleep disturbances in their patients.
First and foremost, the evidence suggesting that patients with FND may overestimate their sleep quality highlights the importance of integrating objective sleep assessments into routine clinical practice. By employing tools like actigraphy alongside subjective self-report instruments such as the Pittsburgh Sleep Quality Index (PSQI), clinicians can obtain a more comprehensive view of a patient’s sleep health. This dual approach would not only facilitate better diagnostic accuracy but also assist in tailoring individualized treatment plans that specifically target the identified sleep issues.
Furthermore, the variations in sleep quality reported among different subgroups of FND patients emphasize the need for personalized care strategies. For instance, those presenting with severe movement disorders exhibited significantly poorer sleep metrics compared to individuals with milder symptoms. This variance suggests that clinical interventions should be adapted based on the specific characteristics of a patient’s condition. Enhanced screening protocols to routinely assess sleep disturbances in those with severe motor symptoms may lead to improved patient outcomes by enabling timely interventions.
Additionally, the fact that some participants reported feelings of frustration and confusion regarding their sleep experience indicates that psychological support should be an integral part of the treatment plan. Patients may benefit from cognitive-behavioral approaches aimed at addressing their misconceptions about sleep, reducing anxiety, and improving sleep hygiene practices. Educational resources that demystify the nature of sleep disturbances in FND could empower patients and enhance their engagement in treatment, thereby fostering a sense of agency over their sleep health.
The study’s findings also suggest that clinicians should adopt a holistic approach to managing FND, recognizing the interplay between neurological symptoms and sleep disturbances. By prioritizing sleep quality alongside neurological care, healthcare providers can potentially enhance overall quality of life and functional outcomes for these patients.
In summary, this research highlights the critical need for clinicians to approach sleep assessments in FND patients with a dual lens, utilizing both subjective and objective data. Tailoring individual treatment plans based on the profiles of sleep disturbances can lead to more effective management strategies, ultimately benefiting patient well-being and quality of life.
